Patients With Malignant Peritoneal Mesothelioma clinical trials

Explore recruiting patients with malignant peritoneal mesothelioma clinical trials.

Recruiting patients with malignant peritoneal mesothelioma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Patients With Malignant Peritoneal Mesothelioma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

INTERACT MESO: Intraperitoneal Paclitaxel for Patients with Primary Malignant Peritoneal Mesothelioma – a Phase I/II Dose Escalation and Safety Study

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

Patients With Malignant Peritoneal Mesothelioma trials by city

Patients With Malignant Peritoneal Mesothelioma in Toronto Patients With Malignant Peritoneal Mesothelioma in Vancouver Patients With Malignant Peritoneal Mesothelioma in Montreal Patients With Malignant Peritoneal Mesothelioma in Calgary Patients With Malignant Peritoneal Mesothelioma in Edmonton Patients With Malignant Peritoneal Mesothelioma in Ottawa Patients With Malignant Peritoneal Mesothelioma in Winnipeg Patients With Malignant Peritoneal Mesothelioma in Quebec City Patients With Malignant Peritoneal Mesothelioma in Hamilton Patients With Malignant Peritoneal Mesothelioma in Kitchener Patients With Malignant Peritoneal Mesothelioma in London Patients With Malignant Peritoneal Mesothelioma in Halifax Patients With Malignant Peritoneal Mesothelioma in New York Patients With Malignant Peritoneal Mesothelioma in Los Angeles Patients With Malignant Peritoneal Mesothelioma in Chicago Patients With Malignant Peritoneal Mesothelioma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease